期刊文献+

IL-18、IL-10及其比值与冠状动脉粥样硬化斑块易损性研究进展 被引量:11

Research Progress on Interleukin-18,Interleukin-10,Interleukin-18/Interleukin-10 ratio and the Vulnerability in Coronary Atherosclerosis Plaques
原文传递
导出
摘要 急性冠脉综合征主要是由于具有易损性的冠状动脉粥样硬化斑块发生破裂或蚀损,继发血栓形成,并引起具有严重危害的急性冠状动脉事件。炎症反应是影响冠状动脉粥样硬化斑块易损性的主要因素,参与反应的炎症因子是近年来研究的热点。有研究发现白细胞介素-18(IL-18)作为一个促炎症因子,会增加斑块的易损性,而白细胞介素-10(IL-10)作为主要的抗炎症因子,则具有抗动脉硬化及稳定粥样斑块的作用。IL-18/IL-10的比值代表了机体促炎性与抗炎性动态平衡的状态,其比值失衡可能是影响斑块易损性的重要因素。近来有研究认为,IL-18/IL-10的比值可作为急性冠脉综合征患者近期冠脉事件的预测因子。文章就近几年来有关IL-10、IL-18及其比值与冠状动脉粥样硬化斑块易损性的研究进展作一综述,以探讨其可能的临床意义。 Acute coronary syndromes often result from rupture or erosion of the vulnerable coronary atherosclerotic plaques with thrombosis, and lead to serious acute coronary events. A major pathogenic factor of the vulnerability in coronary atherosclerosis plaques is inflammation and the inflammatory cytokines involved in response have become a hotspot in recent years. Interleukin-18 (IL-18) as a pro-inflammatory cytokine has been suggested to increase the vulnerability of plaque. Conversely, interleukin-10 (IL-10) as the main anti-inflammatory cytokine seems to have a protective role in atherosclerosis and stabilize plaque.IL-18/IL-10 ratio represents the balance between pro-inflammatory and anti-inflammatory cytokines. The ratio imbalance may be an important factor to affect the vulnerability of plaque. Recent studies show that IL-18/IL-10 ratio may be a predictor of recurrent coronary events in patients with ACS. This paper will review the research progress of interleukin-18, interleukin-10 and interleukin-18/interleukin-10 ratio and the vulnerability in coronary atherosclerosis plaques to search for its possible clinical significance.
出处 《现代生物医学进展》 CAS 2009年第22期4387-4389,共3页 Progress in Modern Biomedicine
基金 国家自然科学基金(30971265) 上海青年科技启明星计划A类(08QA14041)
关键词 白细胞介素-18 白细胞介素-10 炎症反应 冠状动脉粥样硬化 斑块 Interleukin-18 Interleukin-10 Inflammation Coronary Atherosclerosis Plaque
作者简介 诸晓枫(1986-),女,本科生,E-mail:carrie915@126.com 通讯作者:李红莉,电话:13917916016,E-mail:liivy@yahoo.cn
  • 相关文献

参考文献18

  • 1Viles-Gonzalez JF, Fuster V, Badimon JJ. Links Between Inflammation and Thrombogenicity in Atherosclerosis [J]. Curr Mol Med, 2006, 6 (5):489-499.
  • 2Li HL, Sun BG. Toll-like receptor 4 in atherosclerosis [J]. J Cell Mol Med, 2007, 11 (1), 88-95.
  • 3Hulthe J, McPheat W, Samnegard A, et al. Plasma interleukin (IL)-18 concentrations is elevated in patients with previous myocardial infarction and related to severity of coronary atherosclerosis independently of C-reactive protein and IL-6 [J]. Atherosclerosis, 2006, 188(2):450-454.
  • 4Nishihira K, Imamura T, Yamashita A, et al. Increased expression of interleukin-10 in unstable plaque obtained by directional coronary atherectomy [J]. Eur Heart J, 2006, 27(14): 1685-1689.
  • 5Chalikias GK, Tziakas DN, Kaski JC, et al. Interleukin-18:Interleukin-10 ratio and in-hospital adverse events in patients with acute coronary syndrome [J]. Atherosclerosis, 2005, 182(1): 135-143.
  • 6Blankenberg S, Luc G, Ducimetiere P, et al. Interleukin-18 and the Risk of Coronary Heart Disease in European Men: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) [J]. Circulation, 2003, 108(20): 2453-2459.
  • 7Mallat Z, Corbaz A, Scoazec A, et al. Expression of Interleukin-18 in Human Atherosclerotic Plaques and Relation to Plaque Instability [J]. Circulation, 2001, 104(14): 1598-1603.
  • 8刘娟,陈丽琴,苏秀兰,陈良光,李时荣.人冠状动脉粥样硬化斑块内白细胞介素6和18及肿瘤坏死因子α表达与斑块稳定性有关[J].中国动脉硬化杂志,2008,16(7):537-540. 被引量:25
  • 9Whitman SC, Ravisankar P, Daugherty A. lnterleukin-18 Enhances Atherosclerosis in Apolipoprotein E-/- Mice Through Release of Interferon-3,[J]. Cric Res, 2002, 90(2): e34-e38.
  • 10de Nooijer R, vonder Thusen JH, Verkleij C J, et al. Overexpression of IL-18 Decreases Intimal Collagen Content and Promotes a Vulnerable Plaque Phenotype in Apolipoprotein-E-Deficient Mice [J]. Arterioscler Thromb Vasc Biol, 2004, 24(12): 2313-2319.

二级参考文献34

共引文献54

同被引文献111

引证文献11

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部